Ignite Creation Date:
2025-12-25 @ 3:03 AM
Ignite Modification Date:
2026-03-13 @ 9:44 PM
Study NCT ID:
NCT06733233
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-12-13
First Post:
2024-12-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Evaluating the Efficacy and Safety of De Trastuzumab (T-DXd) in Combination with Immunotherapy for the Neoadjuvant Treatment of HR-positive HER2 Low-expressing Chinese Patients with Early-stage Breast Cancer
Sponsor:
Guangzhou Women and Children's Medical Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-01-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2028-01-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-01-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-12-10
First Submit QC Date:
None
Study First Post Date:
2024-12-13
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-10
Last Update Post Date:
2024-12-13
Last Update Post Date Type:
ACTUAL